ADVANTIS-MEDICAL-IMAGING
Advantis Medical Imaging announces that it received CE Mark approval for Brainance® MD, its Cloud-Based Neuroimaging software. This market approval allows Brainance® MD to be used as part of the clinical workflow for the advanced processing of Brain MR images.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180320005408/en/
“We feel really excited to make this announcement. This is a significant milestone for our company and the fact that Brainance® MD can now be integrated in the clinical processing workflow fulfills one of Advantis principal goals: to make state-of-the-art processing methodologies available for every doctor, anywhere, anytime. ” said Zoi Giavri, CEO and co-founder of Advantis Medical Imaging.
“This CE Mark approval confirms our capacity for innovation and justifies the entire team’s devotion and effort on striving for increased quality and performance, while bringing added value to the daily clinical practice.” said Paris Ziogkas, COO and co-founder of Advantis Medical Imaging.
About Brainance ® MD
Brainance® MD is a cloud-based software for the display, processing and analysis of Brain MR Images, which include Diffusion Tensor Imaging, DSC Perfusion and Functional MRI all in a unified user environment, allowing this way Fusion among modalities. Brainance® MD is accessible from a web-browser and can support remote and collaborative analysis. Its reporting and visualisation features can assist healthcare professionals on optimising their daily clinical practice, while working with state-of-the art methodologies in a purely zero-footprint platform.
Brainance® MD is compatible with the DICOM standard and can also be seamlessly interconnected with PACS systems.
Brainance® MD is provided as a Software As A Service (SaaS) meeting the needs of larger and smaller organisations, which want to combine high quality of services with increased scalability of their resources.
About Advantis Medical Imaging
Advantis Medical Imaging was founded in 2016 after 5 years of extensive research in the field of advanced neuroimaging and has offices in Athens and Eindhoven. The company makes Medical Imaging more accessible, user-friendly and data driven by merging it with Cloud Technology.
Advantis Medical Imaging will continue making advanced medical image processing more clinically valuable by exploring the integration of deep learning methodologies both in its current and future software solutions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180320005408/en/
Contact:
Advantis Medical Imaging
Mr. Paris Ziogkas | COO & Co-founder
Website:
www.advantis.io
Contact:
info@advantis.io
Tel: +31
858882140
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AB InBev Reports First Quarter 2025 Results8.5.2025 07:03:00 CEST | Press release
Solid start to the year with EBITDA growth at the top-end of our outlook, continued margin expansion and high-single digit Underlying EPS growth Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507671244/en/ AB InBev Strategic Priorities Regulated information1 “Beer is a passion point for consumers. The strength of the beer category and the continued momentum of our megabrands delivered another quarter of profitable growth. EBITDA increased at the top-end of our outlook and the ongoing optimization of our business drove Underlying EPS growth of 7.1%. The consistent execution of our strategy by our teams and partners drove a solid start to the year and reinforces our confidence in delivering on our outlook for 2025.” – Michel Doukeris, CEO, AB InBev Revenue +1.5% Revenue increased by 1.5% with revenue per hl growth of 3.7%. Reported revenue decreased by 6.3%
Rimini Street and ServiceNow Partner with Apsen Farmacêutica to Deliver a Next-Generation Vision of Enterprise-Wide Workflow Automation7.5.2025 18:55:00 CEST | Press release
Pharmaceutical manufacturer layers ServiceNow over its existing SAP ECC 6 ERP platform, enables intelligent workflow and automation for immediate business impact and avoids low ROI spend on expensive, risky vendor-mandated migration to SAP S/4HANA Knowledge 2025 —Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, management and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today at ServiceNow’s annual customer and partner event, Knowledge 2025, announced that Apsen Farmacêutica, a Brazilian pharmaceutical manufacturer, has partnered with Rimini Street and ServiceNow to implement a next-generation vision of enterprise-wide workflow automation. This new vision will enable autonomy across the company to help respond faster to market changes, reduce information silos and improve operational efficiency. This press release features multimedia. View the full release here: https://www.busine
Results from the VirTus Respiratory Research Ltd Human Rhinovirus Challenge Model Used to Advance Altesa BioSciences’ Lead Medicine into Advanced Clinical Trials7.5.2025 18:07:00 CEST | Press release
Study conducted by VirTus Respiratory Research demonstrated that vapendavir has potent antiviral activity and improves symptoms in participants with COPD infected with rhinovirus VirTus Respiratory Research Ltd, a leading respiratory-focused contract research organisation (CRO), today announced that results from their human rhinovirus challenge model in patients with chronic obstructive pulmonary disease (COPD) provided Altesa BioSciences with compelling evidence to advance their lead drug candidate, vapendavir, into large scale, late-stage clinical trials. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507489716/en/ Professor Sebastian Johnston https://www.prnewswire.com/news-releases/altesa-biosciences-details-positive-topline-vapendavir-results-from-phase-2-placebo-controlled-rhinovirus-challenge-study-in-copd-patients-302448650.html Rhinovirus infection is the cause of at least half of the acute respiratory deteriorat
FlightSafety International Announces Major Expansion at Farnborough Airport7.5.2025 17:56:00 CEST | Press release
FlightSafety International (FSI), a global leader in aviation training, is pleased to announce the expansion of its facilities at Farnborough Airport, the home of British aviation and Europe’s leading airport for premium air travel connectivity, highlighting its commitment to enhancing aviation safety and training excellence in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250506583636/en/ Rendering: arriving at FlightSafety International The new FSI centre is expected to open in the second quarter of 2027. Lease terms have been finalised and the planning application was submitted in January. Construction is scheduled to start in late 2025 and finish by early 2027. FSI has operated a training centre at Farnborough Airport since 2004. The new facilities will boost training capacity by 40-50%, enabling more aviation professionals access to FSI's world-class training programmes. The current facility is 4,680 square met
Verimatrix Positioned as a Leader and Ace Performer in the 2025 SPARK MatrixTM for In-App Protection by QKS Group7.5.2025 17:45:00 CEST | Press release
The QKS Group SPARK Matrix™ provides competitive analysis and ranking of the leading In-App Protection vendors.Verimatrix is recognized for its comprehensive in-app protection capabilities, earning strong ratings across both Technology Excellence and Customer Impact in the latest SPARK Matrix™.Verimatrix has also been named an Ace Performer – a recognition given to vendors that demonstrate revenue growth potential, partnership strategy, and customer acquisition – all evaluated over the last one-year period or since the previous SPARK Matrix™ assessment. Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507970501/en/ Verimatrix positioned as a Leader in the 2025 SPARK Matrix™ for In-App Protection by QKS Group. Verimatrix has been recognized for its comprehensive in-app protection capabilities, earning strong ratings across both Technology Excellence and Customer Impact in the latest SPARK Matrix™. The compan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom